ICD1856K ;ALB/MJB - YEARLY DRG UPDATE;8/9/2010
;;18.0;DRG Grouper;**56**;Oct 13, 2000;Build 7
;
; Updates for DRGS 810-999
Q
;
MSDRG ;;MS-DRG^MDC^TYPE^MS-DRG TITLE^WEIGHTS^GEOMETRIC MEAN LOS^
;;810^16^MED^MAJOR HEMATOL/IMMUN DIAG EXC SICKLE CELL CRISIS & COAGUL W/O CC/MCC^0.8718^2.8^3.5
;;811^16^MED^RED BLOOD CELL DISORDERS W MCC^1.2182^3.7^5.0
;;812^16^MED^RED BLOOD CELL DISORDERS W/O MCC^0.7920^2.7^3.5
;;813^16^MED^COAGULATION DISORDERS^1.5098^3.6^5.0
;;814^16^MED^RETICULOENDOTHELIAL & IMMUNITY DISORDERS W MCC^1.6769^5.0^6.7
;;815^16^MED^RETICULOENDOTHELIAL & IMMUNITY DISORDERS W CC^0.9811^3.5^4.5
;;816^16^MED^RETICULOENDOTHELIAL & IMMUNITY DISORDERS W/O CC/MCC^0.7187^2.6^3.2
;;820^17^SURG^LYMPHOMA & LEUKEMIA W MAJOR O.R. PROCEDURE W MCC^6.0717^13.1^17.2
;;821^17^SURG^LYMPHOMA & LEUKEMIA W MAJOR O.R. PROCEDURE W CC^2.3666^5.0^7.1
;;822^17^SURG^LYMPHOMA & LEUKEMIA W MAJOR O.R. PROCEDURE W/O CC/MCC^1.2183^2.3^3.0
;;823^17^SURG^LYMPHOMA & NON-ACUTE LEUKEMIA W OTHER O.R. PROC W MCC^4.4598^11.9^15.5
;;824^17^SURG^LYMPHOMA & NON-ACUTE LEUKEMIA W OTHER O.R. PROC W CC^2.3193^6.4^8.4
;;825^17^SURG^LYMPHOMA & NON-ACUTE LEUKEMIA W OTHER O.R. PROC W/O CC/MCC^1.2762^2.9^4.1
;;826^17^SURG^MYELOPROLIF DISORD OR POORLY DIFF NEOPL W MAJ O.R. PROC W MCC^5.0537^11.1^14.2
;;827^17^SURG^MYELOPROLIF DISORD OR POORLY DIFF NEOPL W MAJ O.R. PROC W CC^2.2658^5.5^7.2
;;828^17^SURG^MYELOPROLIF DISORD OR POORLY DIFF NEOPL W MAJ O.R. PROC W/O CC/MCC^1.3082^2.7^3.4
;;829^17^SURG^MYELOPROLIF DISORD OR POORLY DIFF NEOPL W OTHER O.R. PROC W CC/MCC^2.8560^6.6^9.8
;;830^17^SURG^MYELOPROLIF DISORD OR POORLY DIFF NEOPL W OTHER O.R. PROC W/O CC/MCC^1.1616^2.3^3.1
;;834^17^MED^ACUTE LEUKEMIA W/O MAJOR O.R. PROCEDURE W MCC^5.3606^10.5^17.0
;;835^17^MED^ACUTE LEUKEMIA W/O MAJOR O.R. PROCEDURE W CC^2.3640^5.3^8.9
;;836^17^MED^ACUTE LEUKEMIA W/O MAJOR O.R. PROCEDURE W/O CC/MCC^1.0967^2.9^4.3
;;837^17^MED^CHEMO W ACUTE LEUKEMIA AS SDX OR W HIGH DOSE CHEMO AGENT W MCC^6.5055^17.5^22.9
;;838^17^MED^CHEMO W ACUTE LEUKEMIA AS SDX W CC OR HIGH DOSE CHEMO AGENT^3.2689^8.1^12.1
;;839^17^MED^CHEMO W ACUTE LEUKEMIA AS SDX W/O CC/MCC^1.2623^4.7^5.6
;;840^17^MED^LYMPHOMA & NON-ACUTE LEUKEMIA W MCC^3.0350^7.8^10.8
;;841^17^MED^LYMPHOMA & NON-ACUTE LEUKEMIA W CC^1.6342^5.0^6.6
;;842^17^MED^LYMPHOMA & NON-ACUTE LEUKEMIA W/O CC/MCC^1.0133^3.1^4.1
;;843^17^MED^OTHER MYELOPROLIF DIS OR POORLY DIFF NEOPL DIAG W MCC^1.8899^5.8^7.8
;;844^17^MED^OTHER MYELOPROLIF DIS OR POORLY DIFF NEOPL DIAG W CC^1.1750^4.2^5.4
;;845^17^MED^OTHER MYELOPROLIF DIS OR POORLY DIFF NEOPL DIAG W/O CC/MCC^0.7966^2.8^3.6
;;846^17^MED^CHEMOTHERAPY W/O ACUTE LEUKEMIA AS SECONDARY DIAGNOSIS W MCC^2.2853^5.6^8.0
;;847^17^MED^CHEMOTHERAPY W/O ACUTE LEUKEMIA AS SECONDARY DIAGNOSIS W CC^1.0146^2.8^3.4
;;848^17^MED^CHEMOTHERAPY W/O ACUTE LEUKEMIA AS SECONDARY DIAGNOSIS W/O CC/MCC^0.7643^2.3^2.9
;;849^17^MED^RADIOTHERAPY^1.3127^4.3^5.8
;;853^18^SURG^INFECTIOUS & PARASITIC DISEASES W O.R. PROCEDURE W MCC^5.4668^11.6^15.0
;;854^18^SURG^INFECTIOUS & PARASITIC DISEASES W O.R. PROCEDURE W CC^2.6551^7.8^9.4
;;855^18^SURG^INFECTIOUS & PARASITIC DISEASES W O.R. PROCEDURE W/O CC/MCC^1.6008^3.8^5.5
;;856^18^SURG^POSTOPERATIVE OR POST-TRAUMATIC INFECTIONS W O.R. PROC W MCC^4.9588^10.9^14.5
;;857^18^SURG^POSTOPERATIVE OR POST-TRAUMATIC INFECTIONS W O.R. PROC W CC^2.0726^6.0^7.6
;;858^18^SURG^POSTOPERATIVE OR POST-TRAUMATIC INFECTIONS W O.R. PROC W/O CC/MCC^1.3212^4.1^5.0
;;862^18^MED^POSTOPERATIVE & POST-TRAUMATIC INFECTIONS W MCC^1.9223^5.7^7.5
;;863^18^MED^POSTOPERATIVE & POST-TRAUMATIC INFECTIONS W/O MCC^0.9943^3.9^4.8
;;864^18^MED^FEVER^0.8337^3.0^3.7
;;865^18^MED^VIRAL ILLNESS W MCC^1.5809^4.4^6.2
;;866^18^MED^VIRAL ILLNESS W/O MCC^0.7446^2.8^3.5
;;867^18^MED^OTHER INFECTIOUS & PARASITIC DISEASES DIAGNOSES W MCC^2.5523^6.9^9.3
;;868^18^MED^OTHER INFECTIOUS & PARASITIC DISEASES DIAGNOSES W CC^1.0816^4.0^5.0
;;869^18^MED^OTHER INFECTIOUS & PARASITIC DISEASES DIAGNOSES W/O CC/MCC^0.6724^2.8^3.4
;;870^18^MED^SEPTICEMIA OR SEVERE SEPSIS W MV 96+ HOURS^5.8339^12.7^14.9
;;871^18^MED^SEPTICEMIA OR SEVERE SEPSIS W/O MV 96+ HOURS W MCC^1.9090^5.3^7.0
;;872^18^MED^SEPTICEMIA OR SEVERE SEPSIS W/O MV 96+ HOURS W/O MCC^1.1339^4.3^5.2
;;876^19^SURG^O.R. PROCEDURE W PRINCIPAL DIAGNOSES OF MENTAL ILLNESS^2.8319^7.6^12.3
;;880^19^MED^ACUTE ADJUSTMENT REACTION & PSYCHOSOCIAL DYSFUNCTION^0.6337^2.3^3.0
;;881^19^MED^DEPRESSIVE NEUROSES^0.6156^3.2^4.2
;;882^19^MED^NEUROSES EXCEPT DEPRESSIVE^0.6566^3.3^4.6
;;883^19^MED^DISORDERS OF PERSONALITY & IMPULSE CONTROL^1.1864^4.8^7.9
;;884^19^MED^ORGANIC DISTURBANCES & MENTAL RETARDATION^0.9529^4.0^5.3
;;885^19^MED^PSYCHOSES^0.9209^5.4^7.3
;;886^19^MED^BEHAVIORAL & DEVELOPMENTAL DISORDERS^0.7466^3.9^5.7
;;887^19^MED^OTHER MENTAL DISORDER DIAGNOSES^0.8189^2.9^4.5
;;894^20^MED^ALCOHOL/DRUG ABUSE OR DEPENDENCE, LEFT AMA^0.4304^2.1^3.0
;;895^20^MED^ALCOHOL/DRUG ABUSE OR DEPENDENCE W REHABILITATION THERAPY^1.0952^9.2^11.9
;;896^20^MED^ALCOHOL/DRUG ABUSE OR DEPENDENCE W/O REHABILITATION THERAPY W MCC^1.4555^4.7^6.4
;;897^20^MED^ALCOHOL/DRUG ABUSE OR DEPENDENCE W/O REHABILITATION THERAPY W/O MCC^0.6687^3.2^4.0
;;901^21^SURG^WOUND DEBRIDEMENTS FOR INJURIES W MCC^4.1030^9.2^14.4
;;902^21^SURG^WOUND DEBRIDEMENTS FOR INJURIES W CC^1.7938^5.4^7.5
;;903^21^SURG^WOUND DEBRIDEMENTS FOR INJURIES W/O CC/MCC^1.0562^3.1^4.1
;;904^21^SURG^SKIN GRAFTS FOR INJURIES W CC/MCC^3.1057^7.0^10.7
;;905^21^SURG^SKIN GRAFTS FOR INJURIES W/O CC/MCC^1.1702^3.4^4.5
;;906^21^SURG^HAND PROCEDURES FOR INJURIES^1.0566^2.3^3.3
;;907^21^SURG^OTHER O.R. PROCEDURES FOR INJURIES W MCC^3.9661^7.8^11.3
;;908^21^SURG^OTHER O.R. PROCEDURES FOR INJURIES W CC^1.9298^4.6^6.0
;;909^21^SURG^OTHER O.R. PROCEDURES FOR INJURIES W/O CC/MCC^1.1612^2.5^3.3
;;913^21^MED^TRAUMATIC INJURY W MCC^1.2458^3.9^5.2
;;914^21^MED^TRAUMATIC INJURY W/O MCC^0.7097^2.5^3.2
;;915^21^MED^ALLERGIC REACTIONS W MCC^1.4600^3.5^5.0
;;916^21^MED^ALLERGIC REACTIONS W/O MCC^0.4836^1.7^2.1
;;917^21^MED^POISONING & TOXIC EFFECTS OF DRUGS W MCC^1.4977^3.6^5.1
;;918^21^MED^POISONING & TOXIC EFFECTS OF DRUGS W/O MCC^0.6228^2.1^2.7
;;919^21^MED^COMPLICATIONS OF TREATMENT W MCC^1.6282^4.4^6.1
;;920^21^MED^COMPLICATIONS OF TREATMENT W CC^0.9629^3.1^4.1
;;921^21^MED^COMPLICATIONS OF TREATMENT W/O CC/MCC^0.6332^2.2^2.8
;;922^21^MED^OTHER INJURY, POISONING & TOXIC EFFECT DIAG W MCC^1.4748^3.9^5.7
;;923^21^MED^OTHER INJURY, POISONING & TOXIC EFFECT DIAG W/O MCC^0.6741^2.3^3.0
;;927^22^SURG^EXTENSIVE BURNS OR FULL THICKNESS BURNS W MV 96+ HRS W SKIN GRAFT^12.1033^20.0^27.3
;;928^22^SURG^FULL THICKNESS BURN W SKIN GRAFT OR INHAL INJ W CC/MCC^4.8909^10.9^15.3
;;929^22^SURG^FULL THICKNESS BURN W SKIN GRAFT OR INHAL INJ W/O CC/MCC^2.1779^4.9^7.2
;;933^22^MED^EXTENSIVE BURNS OR FULL THICKNESS BURNS W MV 96+ HRS W/O SKIN GRAFT^2.2850^2.6^5.4
;;934^22^MED^FULL THICKNESS BURN W/O SKIN GRFT OR INHAL INJ^1.3998^4.0^5.7
;;935^22^MED^NON-EXTENSIVE BURNS^1.2572^3.2^4.8
;;939^23^SURG^O.R. PROC W DIAGNOSES OF OTHER CONTACT W HEALTH SERVICES W MCC^3.0656^6.9^10.3
;;940^23^SURG^O.R. PROC W DIAGNOSES OF OTHER CONTACT W HEALTH SERVICES W CC^1.7678^3.5^5.2
;;941^23^SURG^O.R. PROC W DIAGNOSES OF OTHER CONTACT W HEALTH SERVICES W/O CC/MCC^1.1492^2.0^2.6
;;945^23^MED^REHABILITATION W CC/MCC^1.3312^8.3^10.0
;;946^23^MED^REHABILITATION W/O CC/MCC^1.2889^6.8^7.6
;;947^23^MED^SIGNS & SYMPTOMS W MCC^1.1309^3.7^4.9
;;948^23^MED^SIGNS & SYMPTOMS W/O MCC^0.6923^2.7^3.4
;;949^23^MED^AFTERCARE W CC/MCC^0.9505^2.8^4.5
;;950^23^MED^AFTERCARE W/O CC/MCC^0.5175^2.3^3.3
;;951^23^MED^OTHER FACTORS INFLUENCING HEALTH STATUS^0.7245^2.1^4.7
;;955^24^SURG^CRANIOTOMY FOR MULTIPLE SIGNIFICANT TRAUMA^5.4529^8.2^11.7
;;956^24^SURG^LIMB REATTACHMENT, HIP & FEMUR PROC FOR MULTIPLE SIGNIFICANT TRAUMA^3.6322^6.9^8.5
;;957^24^SURG^OTHER O.R. PROCEDURES FOR MULTIPLE SIGNIFICANT TRAUMA W MCC^6.6017^10.0^14.5
;;958^24^SURG^OTHER O.R. PROCEDURES FOR MULTIPLE SIGNIFICANT TRAUMA W CC^3.7491^7.5^9.2
;;959^24^SURG^OTHER O.R. PROCEDURES FOR MULTIPLE SIGNIFICANT TRAUMA W/O CC/MCC^2.4711^4.5^5.7
;;963^24^MED^OTHER MULTIPLE SIGNIFICANT TRAUMA W MCC^2.8294^5.9^8.5
;;964^24^MED^OTHER MULTIPLE SIGNIFICANT TRAUMA W CC^1.5165^4.4^5.5
;;965^24^MED^OTHER MULTIPLE SIGNIFICANT TRAUMA W/O CC/MCC^1.0114^3.0^3.7
;;969^25^SURG^HIV W EXTENSIVE O.R. PROCEDURE W MCC^5.6158^12.8^17.2
;;970^25^SURG^HIV W EXTENSIVE O.R. PROCEDURE W/O MCC^2.3655^5.8^8.3
;;974^25^MED^HIV W MAJOR RELATED CONDITION W MCC^2.7063^6.9^9.8
;;975^25^MED^HIV W MAJOR RELATED CONDITION W CC^1.3455^4.9^6.4
;;976^25^MED^HIV W MAJOR RELATED CONDITION W/O CC/MCC^0.8649^3.4^4.3
;;977^25^MED^HIV W OR W/O OTHER RELATED CONDITION^1.0783^3.6^4.9
;;981^99^SURG^EXTENSIVE O.R. PROCEDURE UNRELATED TO PRINCIPAL DIAGNOSIS W MCC^5.0673^10.8^13.9
;;982^99^SURG^EXTENSIVE O.R. PROCEDURE UNRELATED TO PRINCIPAL DIAGNOSIS W CC^2.9352^6.3^8.1
;;983^99^SURG^EXTENSIVE O.R. PROCEDURE UNRELATED TO PRINCIPAL DIAGNOSIS W/O CC/MCC^1.7404^3.0^4.1
;;984^99^SURG^PROSTATIC O.R. PROCEDURE UNRELATED TO PRINCIPAL DIAGNOSIS W MCC^3.5294^10.8^13.9
;;985^99^SURG^PROSTATIC O.R. PROCEDURE UNRELATED TO PRINCIPAL DIAGNOSIS W CC^2.1240^6.4^8.7
;;986^99^SURG^PROSTATIC O.R. PROCEDURE UNRELATED TO PRINCIPAL DIAGNOSIS W/O CC/MCC^1.0980^2.6^3.8
;;987^99^SURG^NON-EXTENSIVE O.R. PROC UNRELATED TO PRINCIPAL DIAGNOSIS W MCC^3.4039^8.9^11.7
;;988^99^SURG^NON-EXTENSIVE O.R. PROC UNRELATED TO PRINCIPAL DIAGNOSIS W CC^1.8567^5.3^7.0
;;989^99^SURG^NON-EXTENSIVE O.R. PROC UNRELATED TO PRINCIPAL DIAGNOSIS W/O CC/MCC^1.0583^2.4^3.3
;;998^99^**^PRINCIPAL DIAGNOSIS INVALID AS DISCHARGE DIAGNOSIS^0.0000^0.0^0.0
;;999^99^**^UNGROUPABLE^0.0000^0.0^0.0
;;EXIT
Q
ICD1856K ;ALB/MJB - YEARLY DRG UPDATE;8/9/2010
+1 ;;18.0;DRG Grouper;**56**;Oct 13, 2000;Build 7
+2 ;
+3 ; Updates for DRGS 810-999
+4 QUIT
+5 ;
MSDRG ;;MS-DRG^MDC^TYPE^MS-DRG TITLE^WEIGHTS^GEOMETRIC MEAN LOS^
+1 ;;810^16^MED^MAJOR HEMATOL/IMMUN DIAG EXC SICKLE CELL CRISIS & COAGUL W/O CC/MCC^0.8718^2.8^3.5
+2 ;;811^16^MED^RED BLOOD CELL DISORDERS W MCC^1.2182^3.7^5.0
+3 ;;812^16^MED^RED BLOOD CELL DISORDERS W/O MCC^0.7920^2.7^3.5
+4 ;;813^16^MED^COAGULATION DISORDERS^1.5098^3.6^5.0
+5 ;;814^16^MED^RETICULOENDOTHELIAL & IMMUNITY DISORDERS W MCC^1.6769^5.0^6.7
+6 ;;815^16^MED^RETICULOENDOTHELIAL & IMMUNITY DISORDERS W CC^0.9811^3.5^4.5
+7 ;;816^16^MED^RETICULOENDOTHELIAL & IMMUNITY DISORDERS W/O CC/MCC^0.7187^2.6^3.2
+8 ;;820^17^SURG^LYMPHOMA & LEUKEMIA W MAJOR O.R. PROCEDURE W MCC^6.0717^13.1^17.2
+9 ;;821^17^SURG^LYMPHOMA & LEUKEMIA W MAJOR O.R. PROCEDURE W CC^2.3666^5.0^7.1
+10 ;;822^17^SURG^LYMPHOMA & LEUKEMIA W MAJOR O.R. PROCEDURE W/O CC/MCC^1.2183^2.3^3.0
+11 ;;823^17^SURG^LYMPHOMA & NON-ACUTE LEUKEMIA W OTHER O.R. PROC W MCC^4.4598^11.9^15.5
+12 ;;824^17^SURG^LYMPHOMA & NON-ACUTE LEUKEMIA W OTHER O.R. PROC W CC^2.3193^6.4^8.4
+13 ;;825^17^SURG^LYMPHOMA & NON-ACUTE LEUKEMIA W OTHER O.R. PROC W/O CC/MCC^1.2762^2.9^4.1
+14 ;;826^17^SURG^MYELOPROLIF DISORD OR POORLY DIFF NEOPL W MAJ O.R. PROC W MCC^5.0537^11.1^14.2
+15 ;;827^17^SURG^MYELOPROLIF DISORD OR POORLY DIFF NEOPL W MAJ O.R. PROC W CC^2.2658^5.5^7.2
+16 ;;828^17^SURG^MYELOPROLIF DISORD OR POORLY DIFF NEOPL W MAJ O.R. PROC W/O CC/MCC^1.3082^2.7^3.4
+17 ;;829^17^SURG^MYELOPROLIF DISORD OR POORLY DIFF NEOPL W OTHER O.R. PROC W CC/MCC^2.8560^6.6^9.8
+18 ;;830^17^SURG^MYELOPROLIF DISORD OR POORLY DIFF NEOPL W OTHER O.R. PROC W/O CC/MCC^1.1616^2.3^3.1
+19 ;;834^17^MED^ACUTE LEUKEMIA W/O MAJOR O.R. PROCEDURE W MCC^5.3606^10.5^17.0
+20 ;;835^17^MED^ACUTE LEUKEMIA W/O MAJOR O.R. PROCEDURE W CC^2.3640^5.3^8.9
+21 ;;836^17^MED^ACUTE LEUKEMIA W/O MAJOR O.R. PROCEDURE W/O CC/MCC^1.0967^2.9^4.3
+22 ;;837^17^MED^CHEMO W ACUTE LEUKEMIA AS SDX OR W HIGH DOSE CHEMO AGENT W MCC^6.5055^17.5^22.9
+23 ;;838^17^MED^CHEMO W ACUTE LEUKEMIA AS SDX W CC OR HIGH DOSE CHEMO AGENT^3.2689^8.1^12.1
+24 ;;839^17^MED^CHEMO W ACUTE LEUKEMIA AS SDX W/O CC/MCC^1.2623^4.7^5.6
+25 ;;840^17^MED^LYMPHOMA & NON-ACUTE LEUKEMIA W MCC^3.0350^7.8^10.8
+26 ;;841^17^MED^LYMPHOMA & NON-ACUTE LEUKEMIA W CC^1.6342^5.0^6.6
+27 ;;842^17^MED^LYMPHOMA & NON-ACUTE LEUKEMIA W/O CC/MCC^1.0133^3.1^4.1
+28 ;;843^17^MED^OTHER MYELOPROLIF DIS OR POORLY DIFF NEOPL DIAG W MCC^1.8899^5.8^7.8
+29 ;;844^17^MED^OTHER MYELOPROLIF DIS OR POORLY DIFF NEOPL DIAG W CC^1.1750^4.2^5.4
+30 ;;845^17^MED^OTHER MYELOPROLIF DIS OR POORLY DIFF NEOPL DIAG W/O CC/MCC^0.7966^2.8^3.6
+31 ;;846^17^MED^CHEMOTHERAPY W/O ACUTE LEUKEMIA AS SECONDARY DIAGNOSIS W MCC^2.2853^5.6^8.0
+32 ;;847^17^MED^CHEMOTHERAPY W/O ACUTE LEUKEMIA AS SECONDARY DIAGNOSIS W CC^1.0146^2.8^3.4
+33 ;;848^17^MED^CHEMOTHERAPY W/O ACUTE LEUKEMIA AS SECONDARY DIAGNOSIS W/O CC/MCC^0.7643^2.3^2.9
+34 ;;849^17^MED^RADIOTHERAPY^1.3127^4.3^5.8
+35 ;;853^18^SURG^INFECTIOUS & PARASITIC DISEASES W O.R. PROCEDURE W MCC^5.4668^11.6^15.0
+36 ;;854^18^SURG^INFECTIOUS & PARASITIC DISEASES W O.R. PROCEDURE W CC^2.6551^7.8^9.4
+37 ;;855^18^SURG^INFECTIOUS & PARASITIC DISEASES W O.R. PROCEDURE W/O CC/MCC^1.6008^3.8^5.5
+38 ;;856^18^SURG^POSTOPERATIVE OR POST-TRAUMATIC INFECTIONS W O.R. PROC W MCC^4.9588^10.9^14.5
+39 ;;857^18^SURG^POSTOPERATIVE OR POST-TRAUMATIC INFECTIONS W O.R. PROC W CC^2.0726^6.0^7.6
+40 ;;858^18^SURG^POSTOPERATIVE OR POST-TRAUMATIC INFECTIONS W O.R. PROC W/O CC/MCC^1.3212^4.1^5.0
+41 ;;862^18^MED^POSTOPERATIVE & POST-TRAUMATIC INFECTIONS W MCC^1.9223^5.7^7.5
+42 ;;863^18^MED^POSTOPERATIVE & POST-TRAUMATIC INFECTIONS W/O MCC^0.9943^3.9^4.8
+43 ;;864^18^MED^FEVER^0.8337^3.0^3.7
+44 ;;865^18^MED^VIRAL ILLNESS W MCC^1.5809^4.4^6.2
+45 ;;866^18^MED^VIRAL ILLNESS W/O MCC^0.7446^2.8^3.5
+46 ;;867^18^MED^OTHER INFECTIOUS & PARASITIC DISEASES DIAGNOSES W MCC^2.5523^6.9^9.3
+47 ;;868^18^MED^OTHER INFECTIOUS & PARASITIC DISEASES DIAGNOSES W CC^1.0816^4.0^5.0
+48 ;;869^18^MED^OTHER INFECTIOUS & PARASITIC DISEASES DIAGNOSES W/O CC/MCC^0.6724^2.8^3.4
+49 ;;870^18^MED^SEPTICEMIA OR SEVERE SEPSIS W MV 96+ HOURS^5.8339^12.7^14.9
+50 ;;871^18^MED^SEPTICEMIA OR SEVERE SEPSIS W/O MV 96+ HOURS W MCC^1.9090^5.3^7.0
+51 ;;872^18^MED^SEPTICEMIA OR SEVERE SEPSIS W/O MV 96+ HOURS W/O MCC^1.1339^4.3^5.2
+52 ;;876^19^SURG^O.R. PROCEDURE W PRINCIPAL DIAGNOSES OF MENTAL ILLNESS^2.8319^7.6^12.3
+53 ;;880^19^MED^ACUTE ADJUSTMENT REACTION & PSYCHOSOCIAL DYSFUNCTION^0.6337^2.3^3.0
+54 ;;881^19^MED^DEPRESSIVE NEUROSES^0.6156^3.2^4.2
+55 ;;882^19^MED^NEUROSES EXCEPT DEPRESSIVE^0.6566^3.3^4.6
+56 ;;883^19^MED^DISORDERS OF PERSONALITY & IMPULSE CONTROL^1.1864^4.8^7.9
+57 ;;884^19^MED^ORGANIC DISTURBANCES & MENTAL RETARDATION^0.9529^4.0^5.3
+58 ;;885^19^MED^PSYCHOSES^0.9209^5.4^7.3
+59 ;;886^19^MED^BEHAVIORAL & DEVELOPMENTAL DISORDERS^0.7466^3.9^5.7
+60 ;;887^19^MED^OTHER MENTAL DISORDER DIAGNOSES^0.8189^2.9^4.5
+61 ;;894^20^MED^ALCOHOL/DRUG ABUSE OR DEPENDENCE, LEFT AMA^0.4304^2.1^3.0
+62 ;;895^20^MED^ALCOHOL/DRUG ABUSE OR DEPENDENCE W REHABILITATION THERAPY^1.0952^9.2^11.9
+63 ;;896^20^MED^ALCOHOL/DRUG ABUSE OR DEPENDENCE W/O REHABILITATION THERAPY W MCC^1.4555^4.7^6.4
+64 ;;897^20^MED^ALCOHOL/DRUG ABUSE OR DEPENDENCE W/O REHABILITATION THERAPY W/O MCC^0.6687^3.2^4.0
+65 ;;901^21^SURG^WOUND DEBRIDEMENTS FOR INJURIES W MCC^4.1030^9.2^14.4
+66 ;;902^21^SURG^WOUND DEBRIDEMENTS FOR INJURIES W CC^1.7938^5.4^7.5
+67 ;;903^21^SURG^WOUND DEBRIDEMENTS FOR INJURIES W/O CC/MCC^1.0562^3.1^4.1
+68 ;;904^21^SURG^SKIN GRAFTS FOR INJURIES W CC/MCC^3.1057^7.0^10.7
+69 ;;905^21^SURG^SKIN GRAFTS FOR INJURIES W/O CC/MCC^1.1702^3.4^4.5
+70 ;;906^21^SURG^HAND PROCEDURES FOR INJURIES^1.0566^2.3^3.3
+71 ;;907^21^SURG^OTHER O.R. PROCEDURES FOR INJURIES W MCC^3.9661^7.8^11.3
+72 ;;908^21^SURG^OTHER O.R. PROCEDURES FOR INJURIES W CC^1.9298^4.6^6.0
+73 ;;909^21^SURG^OTHER O.R. PROCEDURES FOR INJURIES W/O CC/MCC^1.1612^2.5^3.3
+74 ;;913^21^MED^TRAUMATIC INJURY W MCC^1.2458^3.9^5.2
+75 ;;914^21^MED^TRAUMATIC INJURY W/O MCC^0.7097^2.5^3.2
+76 ;;915^21^MED^ALLERGIC REACTIONS W MCC^1.4600^3.5^5.0
+77 ;;916^21^MED^ALLERGIC REACTIONS W/O MCC^0.4836^1.7^2.1
+78 ;;917^21^MED^POISONING & TOXIC EFFECTS OF DRUGS W MCC^1.4977^3.6^5.1
+79 ;;918^21^MED^POISONING & TOXIC EFFECTS OF DRUGS W/O MCC^0.6228^2.1^2.7
+80 ;;919^21^MED^COMPLICATIONS OF TREATMENT W MCC^1.6282^4.4^6.1
+81 ;;920^21^MED^COMPLICATIONS OF TREATMENT W CC^0.9629^3.1^4.1
+82 ;;921^21^MED^COMPLICATIONS OF TREATMENT W/O CC/MCC^0.6332^2.2^2.8
+83 ;;922^21^MED^OTHER INJURY, POISONING & TOXIC EFFECT DIAG W MCC^1.4748^3.9^5.7
+84 ;;923^21^MED^OTHER INJURY, POISONING & TOXIC EFFECT DIAG W/O MCC^0.6741^2.3^3.0
+85 ;;927^22^SURG^EXTENSIVE BURNS OR FULL THICKNESS BURNS W MV 96+ HRS W SKIN GRAFT^12.1033^20.0^27.3
+86 ;;928^22^SURG^FULL THICKNESS BURN W SKIN GRAFT OR INHAL INJ W CC/MCC^4.8909^10.9^15.3
+87 ;;929^22^SURG^FULL THICKNESS BURN W SKIN GRAFT OR INHAL INJ W/O CC/MCC^2.1779^4.9^7.2
+88 ;;933^22^MED^EXTENSIVE BURNS OR FULL THICKNESS BURNS W MV 96+ HRS W/O SKIN GRAFT^2.2850^2.6^5.4
+89 ;;934^22^MED^FULL THICKNESS BURN W/O SKIN GRFT OR INHAL INJ^1.3998^4.0^5.7
+90 ;;935^22^MED^NON-EXTENSIVE BURNS^1.2572^3.2^4.8
+91 ;;939^23^SURG^O.R. PROC W DIAGNOSES OF OTHER CONTACT W HEALTH SERVICES W MCC^3.0656^6.9^10.3
+92 ;;940^23^SURG^O.R. PROC W DIAGNOSES OF OTHER CONTACT W HEALTH SERVICES W CC^1.7678^3.5^5.2
+93 ;;941^23^SURG^O.R. PROC W DIAGNOSES OF OTHER CONTACT W HEALTH SERVICES W/O CC/MCC^1.1492^2.0^2.6
+94 ;;945^23^MED^REHABILITATION W CC/MCC^1.3312^8.3^10.0
+95 ;;946^23^MED^REHABILITATION W/O CC/MCC^1.2889^6.8^7.6
+96 ;;947^23^MED^SIGNS & SYMPTOMS W MCC^1.1309^3.7^4.9
+97 ;;948^23^MED^SIGNS & SYMPTOMS W/O MCC^0.6923^2.7^3.4
+98 ;;949^23^MED^AFTERCARE W CC/MCC^0.9505^2.8^4.5
+99 ;;950^23^MED^AFTERCARE W/O CC/MCC^0.5175^2.3^3.3
+100 ;;951^23^MED^OTHER FACTORS INFLUENCING HEALTH STATUS^0.7245^2.1^4.7
+101 ;;955^24^SURG^CRANIOTOMY FOR MULTIPLE SIGNIFICANT TRAUMA^5.4529^8.2^11.7
+102 ;;956^24^SURG^LIMB REATTACHMENT, HIP & FEMUR PROC FOR MULTIPLE SIGNIFICANT TRAUMA^3.6322^6.9^8.5
+103 ;;957^24^SURG^OTHER O.R. PROCEDURES FOR MULTIPLE SIGNIFICANT TRAUMA W MCC^6.6017^10.0^14.5
+104 ;;958^24^SURG^OTHER O.R. PROCEDURES FOR MULTIPLE SIGNIFICANT TRAUMA W CC^3.7491^7.5^9.2
+105 ;;959^24^SURG^OTHER O.R. PROCEDURES FOR MULTIPLE SIGNIFICANT TRAUMA W/O CC/MCC^2.4711^4.5^5.7
+106 ;;963^24^MED^OTHER MULTIPLE SIGNIFICANT TRAUMA W MCC^2.8294^5.9^8.5
+107 ;;964^24^MED^OTHER MULTIPLE SIGNIFICANT TRAUMA W CC^1.5165^4.4^5.5
+108 ;;965^24^MED^OTHER MULTIPLE SIGNIFICANT TRAUMA W/O CC/MCC^1.0114^3.0^3.7
+109 ;;969^25^SURG^HIV W EXTENSIVE O.R. PROCEDURE W MCC^5.6158^12.8^17.2
+110 ;;970^25^SURG^HIV W EXTENSIVE O.R. PROCEDURE W/O MCC^2.3655^5.8^8.3
+111 ;;974^25^MED^HIV W MAJOR RELATED CONDITION W MCC^2.7063^6.9^9.8
+112 ;;975^25^MED^HIV W MAJOR RELATED CONDITION W CC^1.3455^4.9^6.4
+113 ;;976^25^MED^HIV W MAJOR RELATED CONDITION W/O CC/MCC^0.8649^3.4^4.3
+114 ;;977^25^MED^HIV W OR W/O OTHER RELATED CONDITION^1.0783^3.6^4.9
+115 ;;981^99^SURG^EXTENSIVE O.R. PROCEDURE UNRELATED TO PRINCIPAL DIAGNOSIS W MCC^5.0673^10.8^13.9
+116 ;;982^99^SURG^EXTENSIVE O.R. PROCEDURE UNRELATED TO PRINCIPAL DIAGNOSIS W CC^2.9352^6.3^8.1
+117 ;;983^99^SURG^EXTENSIVE O.R. PROCEDURE UNRELATED TO PRINCIPAL DIAGNOSIS W/O CC/MCC^1.7404^3.0^4.1
+118 ;;984^99^SURG^PROSTATIC O.R. PROCEDURE UNRELATED TO PRINCIPAL DIAGNOSIS W MCC^3.5294^10.8^13.9
+119 ;;985^99^SURG^PROSTATIC O.R. PROCEDURE UNRELATED TO PRINCIPAL DIAGNOSIS W CC^2.1240^6.4^8.7
+120 ;;986^99^SURG^PROSTATIC O.R. PROCEDURE UNRELATED TO PRINCIPAL DIAGNOSIS W/O CC/MCC^1.0980^2.6^3.8
+121 ;;987^99^SURG^NON-EXTENSIVE O.R. PROC UNRELATED TO PRINCIPAL DIAGNOSIS W MCC^3.4039^8.9^11.7
+122 ;;988^99^SURG^NON-EXTENSIVE O.R. PROC UNRELATED TO PRINCIPAL DIAGNOSIS W CC^1.8567^5.3^7.0
+123 ;;989^99^SURG^NON-EXTENSIVE O.R. PROC UNRELATED TO PRINCIPAL DIAGNOSIS W/O CC/MCC^1.0583^2.4^3.3
+124 ;;998^99^**^PRINCIPAL DIAGNOSIS INVALID AS DISCHARGE DIAGNOSIS^0.0000^0.0^0.0
+125 ;;999^99^**^UNGROUPABLE^0.0000^0.0^0.0
+126 ;;EXIT
+127 QUIT
